This is the authors' abstract. We don't add key points for this paper.
Regulators of G-protein signaling (RGS) proteins play a central role in modulating signaling via G-protein coupled receptors (GPCRs).Specifically, RGS proteins bind to activated Ga subunits in G-proteins, accelerate the GTP hydrolysis, and thereby rapidly dampen GPCR signaling.Therefore, covalent molecules targeting conserved cysteine residues among RGS proteins have emerged as potential candidates to inhibit the RGS/Ga protein-protein interaction and enhance GPCR signaling.Although these inhibitors bind to conserved cysteine residues among RGS proteins, we have previously suggested [J.Am.Chem.Soc.2018;140:3454-3460] that their potencies and specificities are related to differential protein dynamics among RGS proteins.Using data from all-atom molecular dynamics simulations, we reveal these differences in dynamics of RGS proteins by partitioning the protein structural space into a network of communities that allow allosteric signals to propagate along unique pathways originating at inhibitor binding sites and terminating at the RGS/Ga protein-protein interface.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Vasylevskyi et al. (2021) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: